Page last updated: 2024-08-26

fibrinogen and Acute Promyelocytic Leukemia

fibrinogen has been researched along with Acute Promyelocytic Leukemia in 35 studies

Research

Studies (35)

TimeframeStudies, this research(%)All Research%
pre-19904 (11.43)18.7374
1990's8 (22.86)18.2507
2000's6 (17.14)29.6817
2010's14 (40.00)24.3611
2020's3 (8.57)2.80

Authors

AuthorsStudies
Fang, S; Shi, J; Wang, C; Wang, Y; Zuo, N1
Li, R; Shang, H; Zhao, L1
Arcese, W; Breccia, M; Cicconi, L; De Bellis, E; Del Principe, MI; Di Giuliano, F; Divona, M; Garaci, F; Gurnari, C; Lo-Coco, F; Piciocchi, A; Scalzulli, E; Venditti, A; Voso, MT1
Dai, K; Li, Y; Wu, L; Yu, K; Zhang, Q; Zhang, S1
Bai, Y; Chen, Y; Duan, L; Huo, L; Mi, R; Shi, M; Sun, K; Wang, C; Waqas Ahmed, HA; Wei, X; Wu, D; Xu, F; Yang, R; Yang, X; Zhang, W1
Dalton, WB; DeZern, AE; Ghiaur, G; Gladstone, DE; Gojo, I; Gondek, LP; Hambley, BC; Jasem, J; Levis, MJ; Norsworthy, KJ; Pratz, KW; Prince, G; Shenderov, E; Showel, MM; Smith, BD; Streiff, MB; Webster, JA; Zimmerman, JW1
Brown, V; Chazot, PL; Comer, D; Dib, K; Ennis, M; Jenei, V; Katebe, M; McFarlane, C; Perecko, T; Scheithauer, T; Thurmond, RL1
Han, JY; Kim, DH; Kim, HJ; Kim, SH; Kim, SY; Koh, MS; Lee, HJ; Lee, JH; Lee, S; Oh, SY1
Li, D; Luo, D; Wu, S; Zhang, Y; Zhou, J1
Jin, J; Lou, Y; Mai, W; Meng, H; Qian, W; Suo, S; Tong, H; Wei, J; Yu, W1
Dolan, M; Ngaruiya, C1
Al Mohareb, F; Al Qurashi, F; Al Shanqeeti, A; Al Sharif, F; Al Zahrani, H; Aljurf, M; Chaudhri, N; Iqbal, A; Nurgat, ZA; Owaidah, T; Sahovic, E; Sanz, M; Zaidi, SZ1
Iversen, PO; Sioud, M; Sørensen, DR1
Choi, Y; Jeon, M; Kang, YA; Kim, DY; Kim, JY; Kim, SD; Lee, JH; Lee, KH; Lee, YJ; Lee, YS; Lim, SN; Seol, M1
Amrein, P; Attar, E; Ballen, K; Deangelo, D; Fox, E; Neuberg, D; Singh, H; Stone, R; Wadleigh, M; Werner, L1
Chang, H; Dunn, P; Hung, YS; Kuo, MC; Lin, TL; Shih, LY; Tang, TC; Wang, PN; Wu, JH1
Choudhry, A; DeLoughery, TG1
DIDISHEIM, P; MIBASHAN, RS; TROMBOLD, JS; VANDERVOORT, LE1
Hirota-Kawadobora, M; Kobayashi, H; Okumura, N; Saito, H; Terasawa, F; Tozuka, M1
Brenner, B; Dally, N; Haddad, N; Hoffman, R; Rowe, JM; Sarig, G1
Castaigne, S; Chomienne, C; Daniel, MT; Degos, L; Dombret, H; Fenaux, P; Micléa, JM; Scrobohaci, ML1
Fujimoto, T; Fujimura, K; Kuramoto, A; Noda, M; Shimomura, T; Takafuta, T1
Hvidman, LE; Nielsen, JL; Stentoft, J1
Binder, BR; Kohno, I; Okabe, H; Okajima, K; Soe, G; Takatsuki, K1
Castaigne, S; Daniel, MT; Degos, L; Dombret, H; Ghorra, P; Scrobohaci, ML; Zini, JM1
al-Bitar, M; Estey, EH; Kantarjian, HM; Keating, M; O'Brien, S; Pierce, S; Pollicardo, N1
Alfaro, E; Cygler, AM; Delfino, S; Felice, MS; Rose, AB; Sackmann-Muriel, F; Zubizarreta, PA1
Avvisati, G; Castaman, G; De Sanctis, V; Di Bona, E; Luce Vegna, M; Mandelli, F; Rodeghiero, F1
Gabazza, EC; Kageyama, S; Kato, H; Kumeda, K; Masuya, M; Mori, Y; Nakasaki, T; Nishikawa, M; Okugawa, Y; Shiku, H; Wada, H; Watanabe, R1
Bos, R; Fijnheer, R; Nieuwenhuis, HK; Oudijk, EJ1
Alfaro, J; Chuecas, F; Grebe, G; Lira, P; Loredo, E; Muñoz, B1
Scharf, RE; Schneider, W; Stoffels, U1
Williams, EC1
Dixon, DO; Hester, JP; Keating, MJ; Khorana, S; Ventura, GJ1
Adachi, M; Kondo, S; Nobusawa, A; Ryo, R; Saigo, K; Sugano, W; Yamaguchi, N; Yasunaga, M; Yoneda, N; Yoshida, A1

Reviews

1 review(s) available for fibrinogen and Acute Promyelocytic Leukemia

ArticleYear
Bleeding and thrombosis in acute promyelocytic leukemia.
    American journal of hematology, 2012, Volume: 87, Issue:6

    Topics: Antifibrinolytic Agents; Antineoplastic Agents; Arsenic Trioxide; Arsenicals; Blood Coagulation Tests; Clinical Trials as Topic; Combined Modality Therapy; Cysteine Endopeptidases; Disseminated Intravascular Coagulation; Factor VIIa; Factor VIII; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Multicenter Studies as Topic; Neoplasm Proteins; Oxides; Plasma; Platelet Count; Platelet Transfusion; Recombinant Proteins; Thromboplastin; Thrombosis; Treatment Failure; Tretinoin

2012

Trials

3 trial(s) available for fibrinogen and Acute Promyelocytic Leukemia

ArticleYear
Fibrinogen consumption and use of heparin are risk factors for delayed bleeding during acute promyelocytic leukemia induction.
    Leukemia research, 2019, Volume: 83

    Topics: Adult; Aged; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors

2019
High efficacy and low toxicity of APL induction with concurrent idarubicin/ATRA followed by a novel and simplified outpatient post-remission therapy using single doses of idarubicin and intermittent ATRA.
    Medical oncology (Northwood, London, England), 2010, Volume: 27, Issue:3

    Topics: Adolescent; Adult; Aged; Ambulatory Care; Antineoplastic Combined Chemotherapy Protocols; Clinical Trials as Topic; Dexamethasone; Disease-Free Survival; Drug Administration Schedule; Factor VIII; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Pilot Projects; Remission Induction; Tretinoin; Young Adult

2010
Childhood acute promyelocytic leukemia: no benefit of all-trans-retinoic acid administered in a short-course schedule.
    Pediatric hematology and oncology, 2000, Volume: 17, Issue:2

    Topics: Adolescent; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Child; Child, Preschool; Cytogenetics; Dexamethasone; Disease-Free Survival; Disseminated Intravascular Coagulation; Drug Administration Schedule; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Hemorrhagic Disorders; Humans; Leukemia, Promyelocytic, Acute; Male; Platelet Count; Retrospective Studies; Risk Factors; Survival; Time Factors; Tretinoin

2000

Other Studies

31 other study(ies) available for fibrinogen and Acute Promyelocytic Leukemia

ArticleYear
CD44-fibrinogen binding promotes bleeding in acute promyelocytic leukemia by in situ fibrin(ogen) deposition.
    Blood advances, 2022, 08-09, Volume: 6, Issue:15

    Topics: Animals; Estrone; Fibrin; Fibrinogen; Hemorrhage; Leukemia, Promyelocytic, Acute; Mice

2022
Acute Promyelocytic Leukemia Suggesting a Diagnosis of Myelodysplastic Syndrome: a Diagnostic Dilemma.
    Clinical laboratory, 2022, Sep-01, Volume: 68, Issue:9

    Topics: Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Myelodysplastic Syndromes; Peroxidase

2022
Early intracranial haemorrhages in acute promyelocytic leukaemia: analysis of neuroradiological and clinico-biological parameters.
    British journal of haematology, 2021, Volume: 193, Issue:1

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Case-Control Studies; Child; Female; Fibrinogen; Humans; Hydrocephalus; International Normalized Ratio; Intracranial Hemorrhages; L-Lactate Dehydrogenase; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mortality; Neuroradiography; Precision Medicine; Predictive Value of Tests; Remission Induction; Risk Factors; Tomography, X-Ray Computed; Young Adult

2021
Plasma fibrinogen levels correlate with prognosis and treatment outcome in patients with non-M3 acute myeloid leukemia.
    Leukemia & lymphoma, 2019, Volume: 60, Issue:6

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Biomarkers; Biomarkers, Tumor; Cytogenetic Analysis; Female; Fibrinogen; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Mutation; Prognosis; ROC Curve; Young Adult

2019
The value of FDP/FIB and D-dimer/FIB ratios in predicting high-risk APL-related thrombosis.
    Leukemia research, 2019, Volume: 79

    Topics: Adolescent; Adult; Aged; Blood Coagulation Tests; Child; Child, Preschool; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Predictive Value of Tests; Prognosis; Retrospective Studies; Risk Factors; Thrombosis; Young Adult

2019
The histamine H4 receptor is a potent inhibitor of adhesion-dependent degranulation in human neutrophils.
    Journal of leukocyte biology, 2014, Volume: 96, Issue:3

    Topics: Cell Adhesion; Cell Degranulation; Cell Line, Tumor; Cell Shape; Cells, Cultured; Cytochalasin B; Fibrinogen; Histamine; Humans; Indoles; Leukemia, Promyelocytic, Acute; Lymphocyte Function-Associated Antigen-1; Macrophage-1 Antigen; MAP Kinase Signaling System; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Oximes; p38 Mitogen-Activated Protein Kinases; Piperazines; Piperidines; Protein Conformation; Pyridines; Receptors, G-Protein-Coupled; Receptors, Histamine; Receptors, Histamine H4; RNA, Messenger

2014
Analysis of factors affecting hemorrhagic diathesis and overall survival in patients with acute promyelocytic leukemia.
    The Korean journal of internal medicine, 2015, Volume: 30, Issue:6

    Topics: Adult; Aged; Biomarkers; Chi-Square Distribution; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhagic Disorders; Humans; Kaplan-Meier Estimate; Leukemia, Promyelocytic, Acute; Logistic Models; Male; Middle Aged; Multivariate Analysis; Proportional Hazards Models; Republic of Korea; Retrospective Studies; Risk Factors; Young Adult

2015
Addition of Arsenic Trioxide into Induction Regimens Could Not Accelerate Recovery of Abnormality of Coagulation and Fibrinolysis in Patients with Acute Promyelocytic Leukemia.
    PloS one, 2016, Volume: 11, Issue:1

    Topics: Adolescent; Adult; Aged; Arsenic Trioxide; Arsenicals; Blood Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Oxides; Platelet Count; Prothrombin Time; Retrospective Studies; Tretinoin; Young Adult

2016
Hypofibrinogenemia as a clue in the presumptive diagnosis of acute promyelocytic leukemia.
    Leukemia research, 2016, Volume: 50

    Topics: Adolescent; Adult; Afibrinogenemia; Aged; Aged, 80 and over; Area Under Curve; Biomarkers; Blood Coagulation; Case-Control Studies; Early Diagnosis; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; ROC Curve; Sensitivity and Specificity; Young Adult

2016
Acute Promyelocytic Leukemia Presenting as Focal Neurologic Findings and Deteriorating Mental Status.
    The Journal of emergency medicine, 2017, Volume: 52, Issue:1

    Topics: Blood Platelets; Consciousness; Emergency Service, Hospital; Factor VIII; Fibrinogen; Humans; Intracranial Hemorrhages; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Nervous System Diseases; Thrombocytopenia; Tomography, X-Ray Computed; Tretinoin

2017
A combined immunostimulatory and immunoinhibitory short interference RNA reduces hypercoagulability in a rat model of acute promyelocytic leukaemia.
    Thrombosis and haemostasis, 2010, Volume: 104, Issue:2

    Topics: Animals; Antithrombin III; Biomarkers; Blood Coagulation; Cells, Cultured; Dendritic Cells; Disease Models, Animal; Fibrin Fibrinogen Degradation Products; Fibrinogen; Genetic Therapy; Interleukin-10; Leukemia, Promyelocytic, Acute; Male; Peptide Hydrolases; Plasminogen Activator Inhibitor 1; Rats; Rats, Inbred BN; RNA Interference; RNA, Small Interfering; Thrombophilia; Thromboplastin; Transfection

2010
Significance of fibrinogen, D-dimer, and LDH levels in predicting the risk of bleeding in patients with acute promyelocytic leukemia.
    Leukemia research, 2011, Volume: 35, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Anthracyclines; Antineoplastic Agents; Disease-Free Survival; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Hemorrhage; Humans; Incidence; Kaplan-Meier Estimate; L-Lactate Dehydrogenase; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Retrospective Studies; Risk Factors; Tretinoin; Young Adult

2011
Clinical outcome of patients with acute promyelocytic leukemia and FLT3 mutations.
    American journal of hematology, 2010, Volume: 85, Issue:12

    Topics: Adult; Disease-Free Survival; Female; Fibrinogen; fms-Like Tyrosine Kinase 3; Humans; Inverted Repeat Sequences; Leukemia, Promyelocytic, Acute; Male; Mutation; Risk; Survival Rate; Treatment Outcome; Young Adult

2010
Clinical bleeding events and laboratory coagulation profiles in acute promyelocytic leukemia.
    European journal of haematology, 2012, Volume: 88, Issue:4

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Blood Coagulation; Databases, Factual; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Prothrombin Time; Risk

2012
ACUTE PROMYELOCYTIC LEUKEMIA WITH FIBRINOGEN AND FACTOR V DEFICIENCIES.
    Blood, 1964, Volume: 23

    Topics: Afibrinogenemia; Blood Cell Count; Bone Marrow Examination; Drug Therapy; Factor V Deficiency; Fibrinogen; Humans; Hypoprothrombinemias; Leukemia; Leukemia, Myeloid; Leukemia, Promyelocytic, Acute; Mercaptopurine; Pathology; Statistics as Topic; Thrombocytopenia

1964
The Aalpha-chain 6Ile/Val polymorphism is not associated with plasma fibrinogen levels in Japanese.
    Thrombosis research, 2003, Volume: 112, Issue:4

    Topics: Adult; Amino Acid Substitution; Base Sequence; DNA Primers; Female; Fibrinogen; Humans; Isoleucine; Leukemia, Promyelocytic, Acute; Mutation, Missense; Polymorphism, Genetic; Valine

2003
Predictive factors of bleeding and thrombosis during induction therapy in acute promyelocytic leukemia-a single center experience in 34 patients.
    Thrombosis research, 2005, Volume: 116, Issue:2

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Antineoplastic Agents; Blood Coagulation Tests; Female; Fibrinogen; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Male; Middle Aged; Platelet Count; Predictive Value of Tests; Retrospective Studies; Risk Factors; Thrombophilia; Thrombosis

2005
In vivo thrombin and plasmin activities in patients with acute promyelocytic leukemia (APL): effect of all-trans retinoic acid (ATRA) therapy.
    Leukemia, 1995, Volume: 9, Issue:1

    Topics: Adolescent; Adult; Aged; alpha-2-Antiplasmin; Antifibrinolytic Agents; Blood Coagulation Disorders; Female; Fibrinogen; Fibrinolysin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prospective Studies; Thrombin; Tretinoin

1995
50-kD integrin-associated protein does not detectably influence several functions of glycoprotein IIb-IIIa complex in human platelets.
    Blood, 1995, Sep-15, Volume: 86, Issue:6

    Topics: Animals; Antigens, CD; Blood Platelets; Calcium; Carrier Proteins; CD47 Antigen; Cell Adhesion; CHO Cells; Cricetinae; Cricetulus; Erythrocytes; Fibrinogen; Humans; Integrin beta3; Leukemia, Erythroblastic, Acute; Leukemia, Promyelocytic, Acute; Neutrophils; Platelet Aggregation; Platelet Membrane Glycoproteins; Recombinant Fusion Proteins; Thrombasthenia; Transfection; Tumor Cells, Cultured

1995
All-trans retinoic acid in acute promyelocytic leukemia in late pregnancy.
    Leukemia, 1994, Volume: 8, Issue:9

    Topics: Adult; Female; Fibrinogen; Hemoglobins; Humans; Leukemia, Promyelocytic, Acute; Leukocyte Count; Platelet Count; Pregnancy; Pregnancy Complications, Neoplastic; Pregnancy Outcome; Pregnancy Trimester, Third; Remission Induction; Thrombin Time; Tretinoin

1994
Direct evidence for systemic fibrinogenolysis in patients with acquired alpha 2-plasmin inhibitor deficiency.
    American journal of hematology, 1994, Volume: 45, Issue:1

    Topics: Adult; Aged; alpha-2-Antiplasmin; Aortic Aneurysm, Abdominal; Chromatography, Affinity; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Immunoblotting; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prostatic Neoplasms; Stomach Neoplasms

1994
Coagulation disorders associated with acute promyelocytic leukemia: corrective effect of all-trans retinoic acid treatment.
    Leukemia, 1993, Volume: 7, Issue:1

    Topics: Adolescent; Cell Differentiation; Child; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Prospective Studies; Thrombin; Time Factors; Tretinoin

1993
Secondary acute promyelocytic leukemia. Characteristics and prognosis of 14 patients from a single institution.
    Leukemia, 1996, Volume: 10, Issue:1

    Topics: Adult; Age Factors; Aged; Antineoplastic Combined Chemotherapy Protocols; Female; Fibrinogen; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasms, Second Primary; Prognosis; Remission Induction; Survival Rate

1996
Early haemorrhagic morbidity and mortality during remission induction with or without all-trans retinoic acid in acute promyelocytic leukaemia.
    British journal of haematology, 2000, Volume: 108, Issue:4

    Topics: Adolescent; Adult; Aged; Antibiotics, Antineoplastic; Antineoplastic Agents; Child; Child, Preschool; Drug Therapy, Combination; Evaluation Studies as Topic; Female; Fibrinogen; Hemorrhage; Humans; Idarubicin; Incidence; Infant; Italy; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Morbidity; Multivariate Analysis; Platelet Count; Prospective Studies; Remission Induction; Time Factors; Tretinoin

2000
Decreased tissue factor and tissue-plasminogen activator antigen in relapsed acute promyelocytic leukemia.
    American journal of hematology, 2000, Volume: 64, Issue:3

    Topics: Adolescent; Adult; Antigens; Female; Fibrinogen; Hemostasis; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Recurrence; Thromboplastin; Tissue Plasminogen Activator

2000
Elastase mediated fibrinolysis in acute promyelocytic leukemia.
    Thrombosis and haemostasis, 2000, Volume: 83, Issue:6

    Topics: Adult; Aged; Aged, 80 and over; Antibodies, Monoclonal; Blood Coagulation Tests; Disease Susceptibility; Disseminated Intravascular Coagulation; Female; Fibrin; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Hemorrhage; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Neoplasm Proteins; Pancreatic Elastase; Sepsis

2000
[Intravascular coagulation in acute promyelocytic leukemia: analysis of coagulation and fibrinolysis parameters].
    Revista medica de Chile, 1991, Volume: 119, Issue:9

    Topics: Adolescent; Adult; Aged; Disseminated Intravascular Coagulation; Female; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Thrombocytopenia

1991
Thrombin generation in acute myeloblastic leukemia.
    Haematology and blood transfusion, 1990, Volume: 33

    Topics: Fibrinogen; Fibrinopeptide A; Hemorrhagic Disorders; Humans; Leukemia, Myeloid, Acute; Leukemia, Myelomonocytic, Acute; Leukemia, Promyelocytic, Acute; Leukocyte Count; Neoplastic Stem Cells; Thrombin

1990
Plasma alpha 2-antiplasmin activity. Role in the evaluation and management of fibrinolytic states and other bleeding disorders.
    Archives of internal medicine, 1989, Volume: 149, Issue:8

    Topics: Adolescent; alpha-2-Antiplasmin; Aminocaproic Acid; Blood Coagulation Disorders; Child; Disseminated Intravascular Coagulation; Fibrin Fibrinogen Degradation Products; Fibrinogen; Fibrinolysis; Humans; Leukemia, Promyelocytic, Acute; Liver Diseases; Male; Neoplasm Metastasis

1989
Analysis of risk factors for fatal hemorrhage during induction therapy of patients with acute promyelocytic leukemia.
    Hematologic pathology, 1989, Volume: 3, Issue:1

    Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Blood Transfusion; Disseminated Intravascular Coagulation; Female; Fibrinogen; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute; Male; Middle Aged; Platelet Count; Platelet Transfusion; Remission Induction; Retrospective Studies; Risk Factors

1989
[Antiplasmin drugs and factor XIII concentrates in the treatment of a patient with acute promyelocytic leukemia (M3)].
    Gan no rinsho. Japan journal of cancer clinics, 1989, Volume: 35, Issue:12

    Topics: Adult; Aminocaproic Acid; Antifibrinolytic Agents; Disseminated Intravascular Coagulation; Drug Therapy, Combination; Factor XIII; Female; Fibrinogen; Fibrinolysis; Hemorrhage; Heparin; Humans; Leukemia, Promyelocytic, Acute

1989